forecasted

Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

Opportunity Number: FOR-CA-25-086CFDA Numbers: 93.395, 93.394
Posted: Closed on Jun 16, 2025

Stay Updated

Get notified about new opportunities matching your interests.